Репозиторий OAI—PMH
Репозиторий Российская Офтальмология Онлайн по протоколу OAI-PMH
Конференции
Офтальмологические конференции и симпозиумы
Видео
Видео докладов
Реферат RUS | Реферат ENG | Литература | Полный текст |
УДК: | 617.735 DOI: 10.25276/0235-4160-2023-3-106-111 |
Файзрахманов Р.Р., Босов Э.Д., Богданова В.А., Ваганова Е.Е., Сехина О.Л.
Морфофункциональные особенности пигментного эпителия сетчатки в норме и при возрастной макулярной дегенерации

Национальный медико-хирургический центр им. Н.И. Пирогова Министерства здравоохранения Российской Федерации

Институт усовершенствования врачей ФГБУ «Национального медико-хирургического центра им. Н. И. Пирогова» Минздрава России
1. Lakkaraju A, Umapathy A, Tan LX, Daniele L, Philp NJ, BoeszeBattaglia K, Williams DS. The cell biology of the retinal pigment epithelium. Prog Retin Eye Res. 2020; 100846. doi: 10.1016/j.preteyeres.2020.100846
2. Thomas CJ, Mirza RG, Gill MK. Age-related macular degeneration. Med Clin North Am. 202;105(3): 473–491. doi: 10.1016/j.mcna.2021.01.003
3. Hua R, Zhang M. Imaging characteristics of neovascular and atrophic pachychoroidal spectrum diseases. Front Med (Lausanne). 2022;9: 891397. doi: 10.3389/fmed.2022.891397
4. Baraas RC, Pedersen HR, Knoblauch K, Gilson SJ. Human foveal cone and RPE cell topographies and their correspondence with foveal shape. Invest Ophthalmol Vis Sci. 2022;63(2): 8. doi: 10.1167/iovs.63.2.8
5. Ao J, Wood JP, Chidlow G, Gillies MC, Casson RJ. Retinal pigment epithelium in the pathogenesis of age-related macular degeneration and photobiomodulation as a potential therapy? Clin Exp Ophthalmol. 2018;46(6): 670–686. doi: 10.1111/ceo.13121
6. Caceres PS, Rodriguez-Boulan E. Retinal pigment epithelium polarity in health and blinding diseases. Curr Opin Cell Biol. 2020;62: 37– 45. doi: 10.1016/j.ceb.2019.08.001
7. Vazquez-Dominguez I, Li CHZ, Fadaie Z, Haer-Wigman L, Cremers FPM, Garanto A, Hoyng CB, Roosing S. Identification of a complex allele in IMPG2 as a cause of adult-onset vitelliform macular dystrophy. Invest Ophthalmol Vis Sci. 2022;63(5): 27. doi: 10.1167/iovs.63.5.27
8. Ishikawa M, Sawada Y, Yoshitomi T. Structure, and function of the interphotoreceptor matrix surrounding retinal photoreceptor cells. Exp Eye Res. 2015;133: 3–18. doi: 10.1016/j.exer.2015.02.017
9. Kim J, Lee YJ, Won JY. Molecular mechanisms of retinal pigment epithelium dysfunction in age-related macular degeneration. Int J Mol Sci. 2021;22(22): 12298. doi: 10.3390/ijms222212298
10. Hughes BA, Gallemore RP, Miller SS Transport mechanisms in the retinal pigment epithelium. In: Marmor MF, Wolfensberger TJ (eds). The retinal pigment epithelium. Oxford University Press; New York Oxford. 1998; 103–134. doi: 10.1007/s00231-013-1267-z
11. Handa J.T. How does the macula protect itself from oxidative stress? Mol Asp Med. 2012;33: 418–435. doi: 10.1016/j.mam.2012.03.006
12. Taurone S, Ralli M, Artico M, Madia VN, Scarpa S, Nottola SA, Maconi A, Betti M, Familiari P, Nebbioso M, Costi R, Micera A. Oxidative stress and visual system: a review. EXCLI J. 2022;21: 544–553. doi: 10.17179/excli2022-4663
13. Alexander P, Thomson HA, Luff AJ, Lotery AJ. Eye. 2015;29: 992– 1002. doi: 10.1038/eye.2015.89
14. Hargrave PA. Rhodopsin structure, function, and topography the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2001;42: 3–9. doi: 10.1073/pnas.97.7.3016
15. Bavik C, Henry SH, Zhang Y, Mitts K, McGinn T, Budzynski E, Pashko A, Lieu KL, Zhong S, Blumberg B, Kuksa V, Orme M, Scott I, Fawzi A, Kubota R. Visual cycle modulation as an approach toward preservation of retinal integrity. PLoS One. 2015;10(5): e0124940. doi: 10.1371/journal.pone.0124940
16. Gragg M, Park PS. Detection of misfolded rhodopsin aggregates in cells by Forster resonance energy transfer. Methods Cell Biol. 2019;149: 87– 105. doi: 10.1016/bs.mcb.2018.08.007
17. McConnell HL, Mishra A. Cells of the blood-brain barrier: An overview of the neurovascular unit in health and disease. Methods Mol Biol. 2022;2492: 3–24. doi: 10.1007/978-1-0716-2289-6_1
18. Yang S, Zhou J, Li D. Functions and diseases of the retinal pigment epithelium. Front Pharmacol. 2021;12: 727870. doi: 10.3389/fphar.2021.727870
19. Limoli PG, Vingolo EM, Limoli C, Nebbioso M. Antioxidant and biological properties of mesenchymal cells used for therapy in retinitis pigmentosa. Antioxidants (Basel). 2020;9(10): 983. doi: 10.3390/antiox9100983
20. Slomiany MG, Rosenzweig SA. Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19. Am J Physiol Cell Physiol. 2004;287: C746–C753. doi: 10.1152/ajpcell.00568.2003
21. Thomas CJ, Mirza RG, Gill MK. Age-related macular degeneration. Med Clin North Am. 2021;105(3): 473–491. doi: 10.1016/j.mcna.2021.01.003
22. Schmidt-Erfurth U, Waldstein SM, Deak GG, Kundi M, Simader C. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. Ophthalmology. 2015;122: 822–832. doi: 10.1016/j.ophtha.2014.11.017
23. Cunningham ET, Feiner L, Chung C, Tuomi L, Ehrilch JS. Incidence of retinal pigment epithelium tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration. Ophthalmology. 2011;118: 2447–2452. doi: 10.1016/j.ophtha.2011.05.026
24. Файзрахманов Р.Р., Шишкин М.М., Босов Э.Д. и др. Патоморфология субмакулярного кровоизлияния (обзор). Саратовский научно-медицинский журнал. 2021;17(1): 28–32. [Fayzrakhmanov RR, Shishkin MM, Bosov ED, et al. Pathomorphology of submacular hemorrhage (review). Saratov Journal of Medical Scientific Research. 2021;17(1): 28–32. (In Russ.)]
25. Файзрахманов Р.Р., Босов Э.Д., Шишкин М.М., Воропаев В.Ю., Суханова А.В., Чехонин Е.С., Миронов А.В. Современные аспекты терапии субмакулярных кровоизлияний на фоне макулярной дегенерации. Вестник офтальмологии. 2022;138(2): 87–93. [Fayzrakhmanov RR, Bosov ED, Shishkin MM, Voropaev VYu, Sukhanova AV, Chekhonin ES, Mironov AV. Modern aspects of the treatment of submacular hemorrhages secondary to macular degeneration. The Russian Annals of Ophthalmology. 2022;138(2): 87–93. (In Russ.)]. doi: 10.17116/oftalma202213802187
26. Gass JDM. Idiopathic central serous chorioretinopathy. In: Stereoscopic atlas of macular diseases: diagnosis and treatment. St Louis: Mosby; 1997: 52–70.
27. Chan CK, Abraham P, Meyer CH, Kokame GT, Kaiser PK, Rauser ME, Gross JG, Nuthi AS, Lin SG, Daher NS. Optical coherence tomographymeasured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina. 2010;30(2): 203–211. doi: 10.1097/IAE.0b013e3181babda5
28. Leitritz M, Gelisken F, Inhoffen W, Voelker M, Ziemssen F: Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye. 2008;22: 1504– 1507. doi: 10.1038/eye.2008.145
29. Sastre-Ibanez M, Martinez-Rubio C, Molina-Pallete R, MartinezLopez-Corell P, Wu L, Arevalo JF, Gallego-Pinazo R. Retinal pigment epithelial tears. J Fr Ophtalmol. 2019;42(1): 63–72. doi: 10.1016/j.jfo.2018.04.017
30. Clemens CR, Bastian N, Alten F, Milojcic C, Heiduschka P, Eter N. Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment. Acta Ophthalmol. 2014;92: e50–e56. doi: 10.1111/aos.12234
31. Au A, Santina A, Abraham N, Levin MF, Corradetti G, Sadda S, Sarraf D. Relationship between drusen height and OCT biomarkers of atrophy in non-neovascular AMD. Invest Ophthalmol Vis Sci. 2022;63(11): 24. doi: 10.1167/iovs.63.11.24
32. Karampelas M, Malamos P, Petrou P, et al. Retinal pigment epithelial detachment in age-related macular degeneration. Ophthalmol Ther. 2020;9: 739–756. doi: 10.1007/s40123-020-00291-5
33. Joyiga A, Newsom RSB. Giant retinal epithelium rip secondary to subretinal proliferative vitreoretinopathy. Eye. 2004;18: 960–962. doi: 10.1038/sj.eye.6701376
34. Doguizi S, Ozdek S: Pigment epithelial tears associated with antiVEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration. Retina. 2014;34: 1156–1162. doi: 10.1097/IAE.0000000000000056
35. Chiang A, Chang LK, Yu F, Sarraf D: Predictors of anti-VEGFassociated retinal pigment epithelial tear using FA and OCT analysis. Retina. 2008;28: 1265–1269. doi: 10.1097/IAE.0b013e31817d5d03
36. Yoshida M, Hosoda Y, Akimoto M. Coughing-induced retinal pigment epithelial tear after trabeculectomy combined with pars plana vitrectomy. Am J Ophthalmol Case Rep. 2022;27: 101663. doi: 10.1016/j.ajoc.2022.101663
37. Chang LK, Sarraf D. Tears of the retinal pigment epithelium. Retina. 2007; 27(5): 523–534. doi: 10.1097/iae.0b013e3180a032db
38. Mitchell P, Rodriguez FJ, Joussen AM, Koh A, Eter N, Wong DT, Korobelnik JF, Okada AA. Management of retinal pigment epithelium tear during anti-vascular endothelial growth factor therapy. Retina. 2021;41(4): 671–678. doi: 10.1097/IAE.0000000000003083
39. Romano F, Parrulli S, Battaglia Parodi M, Lupidi M, Cereda M, Staurenghi G, Invernizzi A. Optical coherence tomography features of the repair tissue following RPE tear and their correlation with visual outcomes. Sci Rep. 2021;11(1): 5962. doi: 10.1038/s41598-021-85270-x
40. Tai YC, Huang JC, Sun CC, Yeung L. Bilateral retinal pigment epithelial rips in hypertensive choroidopathy. Taiwan J Ophthalmol. 2016;6: 150– 154. doi: 10.1016/j.tjo.2015.08.001
41. Daien V, Finger RP, Talks JS, et al. Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence. Br J Ophthalmol. 2020;2020. doi: 10.1136/bjophthalmol-2020-317434.bjophthalmol-2020-317434
42. Босов Э.Д., Калинин М.Е., Карпов Г.О., Богданова В.А. Влияние изменений пигментного листка сетчатки на морфофунциональные результаты после хирургии субмакулярных кровоизлияний. Вестник Национального медико-хирургического центра им. Н.И. Пирогова. 2022;17(S4): 25-27. [Bosov ED, Kalinin ME, Karpov GO, Bogdanova VA. Influence of changes in the retinal pigment layer on morphofunctional results after surgery for submacular hemorrhages. Vestnik Nacional'nogo mediko-hirurgicheskogo centra im. N.I. Pirogova. 2022;17(S4): 25–27. (In Russ.)]. doi: 10.25881/20728255_2022_17_4_S1_25
43. Holz FG, Figueroa MS, Bandello F, et al. Ranibizumab treatment in treatment-naive neovascular age-related macular degeneration: results from LUMINOUS, a global real-world study. Retina. 2020;40: 1673–1685. doi: 10.1097/IAE.0000000000002670
44. Sarraf D, Joseph A, Rahimy E. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2014;112: 142–159.
Страница источника: 106
Каталог
Продукции
Организации
Офтальмологические клиники, производители и поставщики оборудования
Издания
Периодические издания
Партнеры
Проекта Российская Офтальмология Онлайн